维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="Minderman"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Mechanism of action of the dual topoisomerase-Ⅰ and -Ⅱ inhibitor TAS-103 and activity against multidrug resistant cells 显示文摘	Minderman H Wrzosek C Cao S	2000	Cancer Chemother Pharmacol2000，45，：	1
2	Modeling chemi- cal process systems via neural eomputation显示文摘	Bhat N V Minderman P A McAvoy J T	1990	IEEE Control Systems Magazine1990，，10：	1
3	The organizational and clinical impact of integrating bedside equipment to an information system: a systematic literature review of patient data management systems (PDMS)显示文摘	Cheung A van Yelden FH Lagerburg V Minderman N	2015	International journal of medical informatics2015，84，3：	1
4	Flow cytometric analysis of breast cancer resistance protein expression and function 显示文摘	Minderman H Suvannasankha A O'Loughlin KL	2002	Cytometry2002，48，：	1
5	Comparison of techniques for themeasurement of carbon dioxide evolution from soil 显示文摘	MINDERMAN G VULTO J C	1973	Pedobiologia1973，13，：	1
6	Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein,multidrug resistance protein,and breast cancer resistance protein显示文摘	Brooks TA Minderman H O' Loughlin KL	2003	Mol Cancer Ther2003，2，11：	1
7	Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function 显示文摘	Suvannasankha A Minderman H O' Loughlin KL	2004	Leukemia2004，18，7：	1
8	Addition,decomposition and accumulation of organic matter in forests显示文摘	Minderman G	1968	J Ecol1968，56，：	1
9	Systemic scleroderma with moderate to severe mitral regurgitation: Unusual three-dimensional echocardiographic features显示文摘	Rami N. Khouzam Ivan A. D’Cruz Maximiliano Arroyo Daniel Minderman	2008	Canadian Journal of Cardiology2008，，2：	1
10	Modeling chemical process systems via neural computation显示文摘	Bhat N V Minderman P A McAvoy T J	1990	IEEE Control Systems Magazine1990，10，3：	1
11	Mechanism of action of the dual topoisomerase- Ⅰ and- Ⅱ inhibitor TAS-103 and activity against m μLtidrug resistant cells显示文摘	Minderman H Wrzosk C Cao S	2000	Cancer Chemother Pharmacol2000，45，1：	1
12	Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4显示文摘	Riddell JR Wang XY Minderman H	2010	J Immunol2010，184，2：	1
13	In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells显示文摘	Minderman H Conroy J M O'Loughlin K L	2005	Mol Cancer Ther2005，4，6：	1
14	VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing ultidrug resistance protein, and breast cancer resistance protein显示文摘	Minderman H O'Loughlin KL Pendyala L	2004	Clin Cancer Res2004，10，5：	1
15	Effects of doxorubicin exposure on cell-cycle kinetics of human leukemia cells studied by bivariate flow cytometric measurement of 5-iodo-2-deoxyuridine incorporation and DNA content显示文摘	Brons PPT Linssen PCM	1991	Exp Hematol1991，19，：	1
16	Incompetence of the internal jugular venous valve:Spectrum of echo-Doppler appearances显示文摘	D′Cruz IA Khouzam RN Minderman DP		0，，09：	1
17	Taxane- based reversal agents modulate drug resistance mediated by P- glycoprotein,multidrug resistance protein, and breast cancer resistance protein显示文摘	Brooks T A Minderman H O' Loughlin K L	2003	Mol Cancer Ther2003，2，11：	1
18	Modeling chemical process systems via neural computation 显示文摘	Bhat N V Minderman P A	1990	IEEE Control System Magazine1990，10，3：	1
19	Sequential admin- istration of irinotecan and cytarabine in the treatment of relapsed and refractery acute myeloid leukemia显示文摘	Minderman H OLoughlin KL Smith PF	2006	Cancer Chemother Pharmaco12006，57，1：	1
20	Bortezomib activity and in vitro interactions with anthraeyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status显示文摘	Minderman H Zhou Y O'Loughlin KL	2007	Cancer Chemother Pharmacol2007，60，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示